A 68-Year-Old Man With Metastatic EGFR+ NSCLC

EP. 1: A 68-Year-Old Man With Metastatic EGFR+ NSCLC

ByJohn Heymach, MD, PhD

May 21st 2020

EP. 2: Improved Outcomes for Patients With EGFR+ NSCLC

ByJohn Heymach, MD, PhD

May 21st 2020

EP. 3: Molecular Testing for Newly Diagnosed NSCLC

ByJohn Heymach, MD, PhD

May 21st 2020

EP. 4: Treatment Options for EGFR+ NSCLC

ByJohn Heymach, MD, PhD

May 21st 2020

EP. 5: Practical Implications of the RELAY Trial in EGFR+ NSCLC

ByJohn Heymach, MD, PhD

May 21st 2020

EP. 6: Manageable Adverse Effects Associated With Treatments for EGFR+ NSCLC

ByJohn Heymach, MD, PhD

May 21st 2020

EP. 7: Repeat Testing at Progression of EGFR+ NSCLC

ByJohn Heymach, MD, PhD

May 21st 2020

EP. 8: Changing Landscape of EGFR+ mNSCLC

ByJohn Heymach, MD, PhD

May 21st 2020